EurekAlert!

MARS trial: decortication and chemotherapy associated with worse outcomes for patients with resectable mesothelioma

(Singapore, September 11, 2023, 10:05 a.m. SGT) – Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events ...
News Medical

Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patients

Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to ...
ascopubs.org

A phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for ...

Trial in progress: Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma. Phase I study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTE immune ...
EurekAlert!

Mount Sinai study strengthens landmark evidence supporting lung-sparing surgery, offering hope for mesothelioma patients

NEW YORK, (February 12, 2026) – A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy ...
ascopubs.org

Are you sure to definitely rule out pleurecomy/decortication plus chemotherapy from treatment of malignant pleural mesothelioma? Our experience with 40 cases

Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC) No significant financial relationships to disclose. This is an ...